Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

New series of uroselective alpha1-adrenoceptor antagonists in development at Abbott

Dec. 7, 1999

Interneuron licenses U.S. rights to urinary incontinence treatment

Nov. 30, 1999

VPA-985: PK/PD of novel aquaretic agent examined in CHF patients

Nov. 25, 1999

Merck's new PDE5 inhibitors useful for impotence, cardiovascular disorders

Nov. 24, 1999

Pfizer's portfolio includes new early-stage compounds for MED

Nov. 23, 1999

Anthranilic acid derivatives from Fujisawa particularly useful for erectile dysfunction

Nov. 22, 1999

Chronic oral treatment with SR-121463 improves water retention in cirrhotic rats

Nov. 16, 1999

VPA-985 as a novel treatment option for hyponatremia in cirrhosis: clinical results

Nov. 15, 1999

Preclinical data reported at ASN support utility of OP-1 in treating renal disease

Nov. 12, 1999

Novel agents for renal diseases with benzimidazole structure

Nov. 11, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...